International Journal of Clinical Pharmacy

, Volume 39, Issue 6, pp 1185–1193 | Cite as

Introducing clinical pharmacy services to cardiovascular clinics at a university hospital in Northern Cyprus

  • Haider Al-Baghdadi
  • Çiğdem Koca Al-Baghdadi
  • Abdikarim Abdi
  • Onur Gültekin
  • Arijana Meštrović
  • Rumeysa Demirdamar
  • Barçın Özcem
  • Bilgen Başgut
Research Article
  • 224 Downloads

Abstract

Background Clinical pharmacists are the primary source of scientifically valid information and advice on the safe, rational, and cost-effective use of medications. However, ward-based clinical pharmacy services are not well optimized in Northern Cyprus. Objective Ward based clinical pharmacy services were introduced and evaluated in cardiovascular clinics. Setting Cardiology and cardiovascular surgery departments in a tertiary university hospital. Methods A prospective interventional study introduced and documented clinical pharmacy services for 120 days. Drug-related problems were classified using the Pharmaceutical Care Network Europe PCNE DRP classification tool V6.2. Main outcome measure Interventions proposed and acceptance rate of recommendations. Results A total of 133 patients were reviewed, and, 81 patients had drug-related problems. Only 402 (93.1%) of the 432 suggested interventions were accepted and regarded as clinically relevant. Drug-related problems primarily involved antihypertensive, diuretic, and antithrombotic agents. Treatment effectiveness was the major type of drug-related problems (107; 49.3%) followed by adverse drug reactions (74; 34.1%). Drug dose and selection were the most frequent causes of drug-related problems. Add/change/stop medications were the most common types of intervention at the prescriber level. A total of 171 (78.8%) of the identified 217 drug-related problems were solved, 4 (1.8%) of the problems were partially solved, 32 (14.7%) problems were unsolved, and 10 (4.6%) problems had unknown outcomes. Conclusion Clinical pharmacy services may have optimized therapy effectiveness and prevent adverse effects. The pharmacist interventions were highly accepted by cardiologists; this may indicate the presence of a great opportunity and need to optimize and implement CPS in other hospitals in Northern Cyprus.

Keywords

Cardiology Clinical pharmacy services Cyprus Drug-related problems PCNE Pharmaceutical care 

Notes

Acknowledgements

The authors are grateful to Rani Dabal, Dr. Bahaaldeen Al-Baghdadi, Dr. Aiser Hassan, Dr. Falahaldeen Al-Baghdadi, and Dr. Roua Dabal for their support and encouragement.

Funding

None.

Conflicts of interest

None.

Supplementary material

11096_2017_534_MOESM1_ESM.docx (25 kb)
Supplementary material 1 (DOCX 25 kb)
11096_2017_534_MOESM2_ESM.docx (28 kb)
Supplementary material 2 (DOCX 27 kb)

References

  1. 1.
    WHO. Cardiovascular diseases (CVDs). World Health Organization. http://www.who.int/mediacentre/factsheets/fs317/en/. Accessed 24 Dec 2016.
  2. 2.
    WHO. NCD country profile 2014: Cyprus. World Health Organization. http://www.who.int/nmh/countries/cyp_en.pdf. Accessed 05 Mar 2017.
  3. 3.
    Bond CA, Raehl CL, Franke T. Clinical pharmacy services and hospital mortality rates. Pharmacotherapy. 1999;19(5):556–64.CrossRefPubMedGoogle Scholar
  4. 4.
    American College of Clinical Pharmacy. The definition of clinical pharmacy. Pharmacotherapy. 2008;28(6):816–7.CrossRefGoogle Scholar
  5. 5.
    American College of Clinical Pharmacy. The strategic plan of the American College of Clinical Pharmacy, 1993. Pharmacotherapy. 1993;13(3):257–61.Google Scholar
  6. 6.
    Allemann SS, Van Mil JW, Botermann L, Berger K, Griese N, Hersberger KE. Pharmaceutical care: the PCNE definition 2013. Int J Clin Pharm. 2014;36(3):544–55.CrossRefPubMedGoogle Scholar
  7. 7.
    Santschi V, Chiolero A, Burnand B, Colosimo AL, Paradis G. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch Intern Med. 2011;171(16):1441–53.CrossRefPubMedGoogle Scholar
  8. 8.
    Morgado MP, Morgado SR, Mendes LC, Pereira LJ, Castelo-branco M. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis. Am J Health Syst Pharm. 2011;68(3):241–53.CrossRefPubMedGoogle Scholar
  9. 9.
    Morgado M, Rolo S, Castelo-branco M. Pharmacist intervention program to enhance hypertension control: a randomised controlled trial. Int J Clin Pharm. 2011;33(1):132–40.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med. 1995;155(18):1949–56.CrossRefPubMedGoogle Scholar
  11. 11.
    Europe PCN. DRP-Classification V6.2. January 14, 2010. Pharmaceutical care network Europe. http://www.pcne.org/upload/files/11_PCNE_classification_V6-2.pdf. Accessed 15 Dec 2016.
  12. 12.
    Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995;274(1):29–34.CrossRefPubMedGoogle Scholar
  13. 13.
    Lesar TS, Lomaestro BM, Pohl H. Medication-prescribing errors in a teaching hospital. A 9-year experience. Arch Intern Med. 1997;157(14):1569–76.CrossRefPubMedGoogle Scholar
  14. 14.
    Evans RS, Pestotnik SL, Classen DC, Horn SD, Bass SB, Burke JP. Preventing adverse drug events in hospitalized patients. Ann Pharmacother. 1994;28(4):523–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Europe PCN. Pharmaceutical care network Europe. http://www.pcne.org/. Accessed 15 Dec 2016.
  16. 16.
    Abdela OA, Bhagavathula AS, Getachew H, Kelifa Y. Risk factors for developing drug-related problems in patients with cardiovascular diseases attending Gondar University Hospital, Ethiopia. J Pharm Bioallied Sci. 2016;8(4):289–95.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Kováčová B, Hasilla J, Ďurišová A. Medication review in inpatients at cardiology clinic/Prehodnotenie terapie u hospitalizovaných pacientov na kardiologickej klinike. Acta Facultatis Pharmaceuticae Universitatis Comenianae. 2015;62(1):15–9.Google Scholar
  18. 18.
    Abraham RR. Drug related problems and reactive pharmacist interventions for inpatients receiving cardiovascular drugs. Int J Basic Med Sci Pharm (IJBMSP). 2014;3(2):42–8.Google Scholar
  19. 19.
    Koh Y, Kutty FBM, Li SC. Drug-related problems in hospitalized patients on polypharmacy: the influence of age and gender. Ther Clin Risk Manag. 2005;1(1):39–48.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Urbina O, Ferrández O, Luque S, Grau S, Mojal S, Pellicer R, et al. Patient risk factors for developing a drug-related problem in a cardiology ward. Ther Clin Risk Manag. 2015;11:9–15.PubMedGoogle Scholar
  21. 21.
    Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013;128(16):1810–52.CrossRefPubMedGoogle Scholar
  22. 22.
    Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370(9582):173–84.CrossRefPubMedGoogle Scholar
  23. 23.
    Nielsen TR, Andersen SE, Rasmussen M, Honoré PH. Clinical pharmacist service in the acute ward. Int J Clin Pharm. 2013;35(6):1137–51.CrossRefPubMedGoogle Scholar
  24. 24.
    Bergkvist Christensen A, Holmbjer L, Midlöv P, Höglund P, Larsson L, Bondesson Å, et al. The process of identifying, solving and preventing drug related problems in the LIMM-study. Int J Clin Pharm. 2011;33(6):1010–8.CrossRefPubMedGoogle Scholar
  25. 25.
    Gillespie U, Alassaad A, Henrohn D, Garmo H, Hammarlund-Udenaes M, Toss H, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med. 2009;169(9):894–900.CrossRefPubMedGoogle Scholar
  26. 26.
    Fertleman M, Barnett N, Patel T. Improving medication management for patients: the effect of a pharmacist on post-admission ward rounds. Qual Saf Health Care. 2005;14(3):207–11.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Al-azzam SI, Shara M, Alzoubi KH, Almahasneh FA, Iflaifel MH. Implementation of clinical pharmacy services at a university hospital in Jordan. Int J Pharm Pract. 2013;21(5):337–40.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Department of Clinical Pharmacy, Faculty of PharmacyNear East UniversityNicosiaTurkey
  2. 2.Pazaryeri Çiğdem PharmacyBilecikTurkey
  3. 3.Pharma Expert Consultancy and EducationZagrebCroatia
  4. 4.European University of LefkeLefkaTurkey
  5. 5.Department of Cardiovascular SurgeryNear East University HospitalNicosiaTurkey

Personalised recommendations